Myriad Genetics | MYGN - Selling And Administration Expenses

Stock Price
4.14
Daily Change
-0.15 -3.50%
Monthly
-28.74%
Yearly
-69.96%
Q1 Forecast
4.16

Myriad Genetics reported $129M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Agilent USD 428M 37M Sep/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Bio-Rad Laboratories USD 206.8M 900K Sep/2025
Bruker USD 247.2M 4.7M Dec/2025
Danaher USD 2.03B 35M Dec/2025
Exact Sciences USD 491.64M 35.94M Sep/2025
Hologic USD 2.5B 2.24B Dec/2025
Illumina USD 283M 27M Dec/2025
J&J USD 6.75B 831M Dec/2025
Mettler Toledo International USD 259.83M 11.43M Dec/2025
Myriad Genetics USD 129M 1.3M Sep/2025
OraSure Technologies USD -0.06 0.05 Sep/2024
Pacific Biosciences Of California USD 43.75M 2.13M Sep/2024
Quest Diagnostics USD 504M 3M Dec/2025
Quidel USD 194.4M 7.5M Dec/2025
Repligen USD 73.66M 2.43M Sep/2025
Revvity USD 251.73M 9.82M Dec/2025
Standard Biotools USD 26.6M 1.5M Sep/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Veracyte USD 51.73M 5.91M Sep/2025
Waters USD 240.01M 25.78M Dec/2025